(EHTH) eHealth - Ratings and Ratios
Marketplace, Medicare, Individual, Family, Ancillary
EHTH EPS (Earnings per Share)
EHTH Revenue
Description: EHTH eHealth
EHealth Inc (NASDAQ:EHTH) is a US-based insurance broker operating in the health insurance marketplace. As a common stock, its performance is influenced by various market and economic factors.
The companys market capitalization stands at $104.81M USD, indicating a relatively small-cap stock with potential for growth. The forward Price-to-Earnings ratio is 13.44, suggesting that investors are pricing in future earnings growth. Return on Equity (RoE) is 4.40%, which, although not exceptionally high, indicates some level of profitability.
Key drivers for EHTHs stock performance include the demand for health insurance, regulatory changes in the healthcare industry, and competition in the online insurance brokerage space. The companys ability to adapt to changing market conditions, such as shifts in consumer behavior and advances in technology, will be crucial to its success.
To evaluate EHTHs potential, investors should monitor KPIs such as revenue growth, customer acquisition costs, and retention rates. The companys ability to scale its online platform and expand its customer base will be essential in driving future growth. Additionally, investors should keep an eye on industry trends, such as the shift towards online insurance sales and the impact of regulatory changes on the health insurance market.
From a technical analysis perspective, EHTHs stock price is currently below its 20-day and 50-day Simple Moving Averages (SMA20 and SMA50), indicating a short-term downtrend. The stocks Beta of 1.058 suggests that it is slightly more volatile than the overall market. Investors should consider these factors when evaluating the stocks potential for future growth.
EHTH Stock Overview
| Market Cap in USD | 119m |
| Sub-Industry | Insurance Brokers |
| IPO / Inception | 2006-10-13 |
EHTH Stock Ratings
| Growth Rating | -49.8% |
| Fundamental | 46.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -21.7% |
| Analyst Rating | 3.40 of 5 |
EHTH Dividends
Currently no dividends paidEHTH Growth Ratios
| Growth Correlation 3m | -34% |
| Growth Correlation 12m | -47.4% |
| Growth Correlation 5y | -79.8% |
| CAGR 5y | -11.09% |
| CAGR/Max DD 3y | -0.16 |
| CAGR/Mean DD 3y | -0.32 |
| Sharpe Ratio 12m | -0.70 |
| Alpha | 0.06 |
| Beta | 0.846 |
| Volatility | 73.86% |
| Current Volume | 237.3k |
| Average Volume 20d | 261.4k |
| Stop Loss | 3.6 (-6.5%) |
| Signal | -1.22 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (39.6m TTM) > 0 and > 6% of Revenue (6% = 32.8m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -1.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 39.81% (prev 50.84%; Δ -11.03pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -21.0m <= Net Income 39.6m (YES >=105%, WARN >=100%) |
| Net Debt (27.8m) to EBITDA (71.3m) ratio: 0.39 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.4m) change vs 12m ago 4.01% (target <= -2.0% for YES) |
| Gross Margin 86.08% (prev 99.72%; Δ -13.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.69% (prev 45.37%; Δ 6.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.36 (EBITDA TTM 71.3m / Interest Expense TTM 10.5m) >= 6 (WARN >= 3) |
Altman Z'' 1.57
| (A) 0.20 = (Total Current Assets 328.2m - Total Current Liabilities 110.2m) / Total Assets 1.08b |
| (B) -0.01 = Retained Earnings (Balance) -12.1m / Total Assets 1.08b |
| (C) 0.05 = EBIT TTM 56.3m / Avg Total Assets 1.06b |
| (D) -0.07 = Book Value of Equity -12.3m / Total Liabilities 165.9m |
| Total Rating: 1.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.35
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield -21.34% = -5.0 |
| 3. FCF Margin -5.70% = -2.14 |
| 4. Debt/Equity 0.14 = 2.49 |
| 5. Debt/Ebitda 1.85 = 0.28 |
| 6. ROIC - WACC (= -0.12)% = -0.15 |
| 7. RoE 4.40% = 0.37 |
| 8. Rev. Trend 10.35% = 0.78 |
| 9. EPS Trend 4.50% = 0.22 |
What is the price of EHTH shares?
Over the past week, the price has changed by +2.12%, over one month by +8.15%, over three months by -5.17% and over the past year by -7.23%.
Is eHealth a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EHTH is around 3.29 USD . This means that EHTH is currently overvalued and has a potential downside of -14.55%.
Is EHTH a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EHTH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.3 | 140.3% |
| Analysts Target Price | 9.3 | 140.3% |
| ValueRay Target Price | 3.6 | -7.8% |
Last update: 2025-09-10 04:36
EHTH Fundamental Data Overview
CCE Cash And Equivalents = 105.2m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 3.1586
P/S = 0.2177
P/B = 0.215
P/EG = 0.7211
Beta = 1.127
Revenue TTM = 547.5m USD
EBIT TTM = 56.3m USD
EBITDA TTM = 71.3m USD
Long Term Debt = 55.7m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 76.7m USD (from shortTermDebt, last quarter)
Debt = 132.3m USD (Calculated: Short Term 76.7m + Long Term 55.7m)
Net Debt = 27.8m USD (from netDebt column, last quarter)
Enterprise Value = 146.3m USD (119.2m + Debt 132.3m - CCE 105.2m)
Interest Coverage Ratio = 5.36 (Ebit TTM 56.3m / Interest Expense TTM 10.5m)
FCF Yield = -21.34% (FCF TTM -31.2m / Enterprise Value 146.3m)
FCF Margin = -5.70% (FCF TTM -31.2m / Revenue TTM 547.5m)
Net Margin = 7.23% (Net Income TTM 39.6m / Revenue TTM 547.5m)
Gross Margin = 86.08% ((Revenue TTM 547.5m - Cost of Revenue TTM 76.2m) / Revenue TTM)
Tobins Q-Ratio = -11.86 (set to none) (Enterprise Value 146.3m / Book Value Of Equity -12.3m)
Interest Expense / Debt = 1.77% (Interest Expense 2.35m / Debt 132.3m)
Taxrate = 47.92% (9.26m / 19.3m)
NOPAT = 29.3m (EBIT 56.3m * (1 - 47.92%))
Current Ratio = 2.98 (Total Current Assets 328.2m / Total Current Liabilities 110.2m)
Debt / Equity = 0.14 (Debt 132.3m / last Quarter total Stockholder Equity 913.8m)
Debt / EBITDA = 1.85 (Net Debt 27.8m / EBITDA 71.3m)
Debt / FCF = -4.24 (Debt 132.3m / FCF TTM -31.2m)
Total Stockholder Equity = 899.0m (last 4 quarters mean)
RoA = 3.66% (Net Income 39.6m, Total Assets 1.08b )
RoE = 4.40% (Net Income TTM 39.6m / Total Stockholder Equity 899.0m)
RoCE = 5.90% (Ebit 56.3m / (Equity 899.0m + L.T.Debt 55.7m))
RoIC = 4.69% (NOPAT 29.3m / Invested Capital 624.9m)
WACC = 4.81% (E(119.2m)/V(251.5m) * Re(9.13%)) + (D(132.3m)/V(251.5m) * Rd(1.77%) * (1-Tc(0.48)))
Shares Correlation 3-Years: 87.88 | Cagr: 0.97%
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -31.2m)
EPS Correlation: 4.50 | EPS CAGR: 14.68% | SUE: 0.81 | # QB: 0
Revenue Correlation: 10.35 | Revenue CAGR: 4.84% | SUE: N/A | # QB: None
Additional Sources for EHTH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle